Sign up to save your podcasts
Or
Share Is the Diabetes 'Holy Grail' in Reach?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Is the Diabetes 'Holy Grail' in Reach?
With empagliflozin, pioglitazone, and liraglutide, we may finally be getting closer to the 'holy grail' of a diabetes drug that also has cardiovascular benefits.
View all episodes
By MedscapeWith empagliflozin, pioglitazone, and liraglutide, we may finally be getting closer to the 'holy grail' of a diabetes drug that also has cardiovascular benefits.